Provided by Tiger Trade Technology Pte. Ltd.

Lixte Biotechnology Holdings Inc.

2.96
-0.1450-4.68%
Volume:35.13K
Turnover:103.63K
Market Cap:25.72M
PE:-2.44
High:3.20
Open:3.20
Low:2.60
Close:3.10
52wk High:6.26
52wk Low:0.6400
Shares:8.70M
Float Shares:7.99M
Volume Ratio:1.98
T/O Rate:0.44%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2110
EPS(LYR):-1.5943
ROE:-130.06%
ROA:-68.32%
PB:10.90
PE(LYR):-1.85

Loading ...

May 12, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 21, 2021

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Apr 13, 2021

Major Issues Report

8-K - Current report
Mar 26, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 02, 2021

Major Issues Report

8-K - Current report
Feb 03, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jan 22, 2021

Major Issues Report

8-K - Current report
Dec 17, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 17, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 17, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 17, 2020

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 17, 2020

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Dec 02, 2020

Major Issues Report

8-K - Current report
Nov 27, 2020

Major Issues Report

8-K - Current report
Nov 19, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 19, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 16, 2020

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Nov 16, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 16, 2020

Correspondence

CORRESP [Cover] - Correspondence
Nov 10, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]